CCEL Q2 2022 Earnings — Cryo-Cell International, Inc. Revenue & Financial Results | Market Cap Arena

CCELCryo-Cell International, Inc.

$26M

Q2 2022 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$8M+5.9% YoY

Gross Profit

$5M71.2% margin

Operating Income

$1M15.6% margin

Net Income

$634,7198.3% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

+5.2%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

$2M

Stock-Based Comp.

$117,462

Balance Sheet

Total Assets

$55M

Total Liabilities

$51M

Stockholders' Equity

$4M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$7M	+5.9%
Gross Profit	$5M	$5M	+9.0%
Operating Income	$1M	$2M	-40.1%
Net Income	$634,719	$1M	-45.8%

Revenue Segments

Processing And Storage Fees

$7M98%

Public Banking

$116,7352%

Product

$36,4000%